Too Consult Sweden AB
28.9.2023 15:33:23 CEST | ACCESS Newswire | Press release
Critical findings from a comprehensive study on child safety products raise urgent concerns, prompting a call for enhanced safety standards and heightened vigilance among parents and caregivers
BREDARYD, SWEDEN / ACCESSWIRE / September 28, 2023 / In a dedicated effort to enhance child safety standards, Too Consult Sweden AB feels obliged to announce the results of our extensive investigation into the safety of retractable "Safety Barriers" (known in Europe) and "Expansion Gates" (known in the U.S.). This comprehensive study encompassed a meticulous analysis of numerous models available in both European and U.S. markets.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Physical laboratory tests were meticulously conducted by the esteemed state-owned Research Institutes of Sweden (RISE), while chemical evaluations were carried out by SGS-CSTC (Standards Technical Services Co., Ltd) in China.
The tests covered the following aspects:
- Product Marking
- Purchase Information
- Instruction for Use - Manual
- Product Registration Card (CPSC 16 CFR 1130), only U.S.
- Protective Height
- Gaps (Hip Probe/Small Torso)
- Protrusion Hazards (Ball-Chain), only EU
- Chemical content test of fabric according to:
* EU: EN71-3:2019+A1:2021, 2009/48/EC TSD
* U.S.: 16 CFR 1303 + CPSIA and HR 4040, 16 CFR 1307/CPSIA section 108 and Moorberg V, North States Industries Inc. out of court settlement and California State, AB 652.
Our findings, which bear significant implications for parents and caregivers alike, highlight the widespread availability of safety devices in both territories. The 24 models subjected to rigorous examination encompassed a wide array of over 90 unique brand names, with our analysis laser-focused on key clauses from the European standard EN1930:2011 and the U.S. standard ASTM F1004-22.
The outcome of our comprehensive testing has unveiled critical concerns, as certain models exhibited defects that have the potential to result in severe or, tragically, even fatal injuries to children. Conversely, a select subset of models showcased a safety design that maximizes child protection.
These findings highlight a troubling pattern of neglect or inadequate comprehension of safety standards within both manufacturers and merchants. Furthermore, they underscore the shortcomings of government consumer watchdogs and consumer organizations in monitoring dangerous products within their respective markets.
For more in-depth information about the study and our testing results, please visit the following link: https://medium.com/too-consult-sweden/safety-research-reveals-alarming-dangers-in-many-retractable-child-safety-gates-sold-on-online-d91c73a05236. An overview of the testing results can be viewed here: https://vimeo.com/867816088
In light of these paramount findings, Too Consult Sweden AB is committed to disseminating this crucial information to the public. Further insights, in-depth analysis, and comprehensive details regarding our research can be provided.
For media inquiries, please contact:
Mattias Larsson, Too Consult Sweden AB
+46 705 700 262
info@tooconsult.se
Contact Information
Mattias Larsson
Manager
info@tooconsult.se
+46 705 700 262
Related Images
|
SOURCE: Too Consult Sweden AB
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/787843/new-safety-research-sheds-light-on-crucial-child-safety-product-concerns
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release
PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path
Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans30.9.2026 15:50:00 CEST | Press release
NEW YORK, NY / ACCESS Newswire / September 30, 2026 / Innodata Inc. (Nasdaq:INOD) today announced the opening of a new R&D laboratory that is designed to generate the data needed to train the next generation of human-like robots and independently validate the performance data that robots generate internally. Innodata developed the lab in collaboration with Vicon, a leader in motion capture who consulted on the lab design and continues to provide technical consulting. The New Jersey-based lab is equipped with high-precision, low-latency infrared optical tracking cameras that measure movement down to the sub-millimeter level-a degree of accuracy that methods such as wearable inertial measurement unit (IMU) sensors and single-camera (monocular) video analysis typically cannot match. The lab addresses an urgent need for high-quality training data for humanoids, industrial robots, and other forms of physical AI. While many other data providers infer 3D motion by analyzing 2D video, Innodata
Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 202630.9.2026 00:45:00 CEST | Press release
THUNDER BAY, ON / ACCESS Newswire / September 29, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU)(OTC PINK:CLRMF) announces that it has filed its unaudited consolidated interim financial statements and management's discussion and analysis for the six-month period ended July 31, 2026, available for viewing on www.sedarplus.ca. Financial HighlightsTotal assets as at July 31, 2026 of $35,465,204Total cash as at July 31, 2026 of $422,500Working capital deficiency as at July 31, 2026 of $3,188,114Shareholder's equity as at July 31, 2026 of $31,803,864 During the six-month period ended July 31, 2026, the Company incurred $164,309 in cost for exploration activities at the Thunder Bay North project. During the second fiscal quarter, the Company focused on finalizing the proposed amalgamation while continuing discussions on Advanced Exploration permitting and re-assessment of past geophysical work to highlight areas of focus for drilling and geophysics in
Continent 8 and FuturePath AI Launch Future8: Accountable AI for Regulated Industries29.9.2026 15:00:00 CEST | Press release
LISBON, PT / ACCESS Newswire / September 29, 2026 / Continent 8 Technologies and FuturePath AI today launched Future8, an AI-native operating company built for regulated operators, formed as a joint venture between the two companies. Announced at SBC Summit Lisbon, Future8 combines FuturePath's enterprise AI applications platform with Continent 8's licensed global operating footprint, enabling the iGaming industry to deploy auditable AI without compromising compliance, data sovereignty and operational control. Built for highly regulated environments, Future8 enables operators to move from AI experimentation to production deployment by embedding governance, approvals and auditability into every workflow from day one. Continent 8 brings licensed data centers and a private global network spanning more than 100 locations, built over 28 years serving the biggest iGaming and online brands, along with AI-enabled Global Capability Centers in India, the Philippines and Bulgaria. The company als
Europe SPAC Summit 2026 Invites European Private Companies to Explore the SPAC Path to U.S. Public Markets29.9.2026 15:00:00 CEST | Press release
NEW YORK, NY AND ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / A growing number of European companies in frontier technologies, critical minerals, advanced manufacturing, defense tech, energy, and consumer sectors are evaluating a merger with a special purpose acquisition company (SPAC) as a faster route to a U.S. listing, a valuation that reflects global investor demand, and access to follow-on capital. The Europe SPAC Summit 2026 (ESPAC'26), co-hosted by AUM Advisors and MBP Global, is inviting the CEOs, CFOs, founders, and board members of late-stage European private companies to The Dolder Grand in Zurich on Thursday, December 10, 2026, to learn how the process works and to meet the investment bankers, institutional investors, and SPAC sponsors who make these transactions happen. Attendance is by invitation only and free of charge for qualified companies. Europe's recent de-SPACs show what is possible. Kyivstar, Ukraine's largest mobile operator, listed on Nasdaq thr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom